Summary by Moomoo AI
Avenue Therapeutics, Inc. has filed a Form S-3 with the Securities and Exchange Commission (SEC) on January 24, 2024, for the registration of 33,080,598 shares of common stock. The registration statement includes a preliminary prospectus detailing the proposed sale of shares by selling stockholders from time to time after the effective date of the Registration Statement. The sale may occur on the Nasdaq Capital Market or through private transactions at fixed or negotiated prices. The company will not receive any proceeds from the sale of shares by the selling stockholders. The registration statement also outlines the rights and obligations of the selling stockholders, including the potential methods of sale, such as block trades, broker transactions, or directly to purchasers. Avenue Therapeutics, a specialty pharmaceutical company, has indicated that the registration is part of its efforts to satisfy certain registration rights granted to the selling stockholders. The company's common stock is listed on the Nasdaq Capital Market under the symbol 'ATXI'.